N. Fehse

发表

Neuroblastoma screening at one year of age.

F. Berthold, B. Hero, C. Spix, 2002, The New England journal of medicine.

Pilot study of reduced‐intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis

J. Panse, N. Kröger, A. Zander, 2005, British journal of haematology.

Farber disease: clinical presentation, pathogenesis and a new approach to treatment

A. Zander, J. Roth, M. Frosch, 2007, Pediatric rheumatology online journal.

Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation

N. Kröger, A. Zander, A. Hinke, 2006, Bone Marrow Transplantation.

Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up

N. Kröger, A. Zander, B. Fehse, 2006, Bone Marrow Transplantation.

Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation.

N. Kröger, A. Zander, B. Fehse, 2003, Journal of hematotherapy & stem cell research.

Caspofungin as secondary prophylaxis or therapy in patients undergoing allogeneic stem cell transplantation with a prior or ongoing history of systemic or invasive fungal infections

J. Panse, N. Kröger, A. Zander, 2008 .

CD34(+)-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation.

N. Kröger, T. Klingebiel, B. Fehse, 2006, Cytotherapy.

Farber’s disease without central nervous system involvement: bone-marrow transplantation provides a promising new approach

J. Roth, M. Frosch, J. Vormoor, 2006, Annals of the rheumatic diseases.